Background: Few studies have assessed the duration of humoral immunity following yellow fever (YF) vaccination in a non-endemic population. We evaluated seropositivity among US resident travellers based on time post-vaccination. Methods: We identified serum samples from US travellers with YF virus-specific plaque reduction neutralization testing (PRNT) performed at CDC from 1988 to 2016. Analyses were conducted to assess the effect of time since vaccination on neutralizing antibody titer counts. Results: Among 234 travellers who had neutralizing antibody testing performed on a specimen obtained ≥1 month after vaccination, 13 received multiple YF vaccinations and 221 had one dose of YF vaccine reported. All 13 who received more than one dose of YF vaccine had a positive PRNT regardless of the amount time since most recent vaccination. Among the 221 travellers with one reported dose of YF vaccine, 155 (70%) were vaccinated within 10 years (range 1 month-9 years) and 66 (30%) were vaccinated ≥10 years (range 10-53 years) prior to serum collection. Among the 155 individuals vaccinated, <10 years prior to serum collection, 146 (94%) had a positive PRNT compared with 82% (54/66) of individuals vaccinated ≥10 years prior to serum collection (P = 0.01). Post-vaccination PRNT titers showed a time-dependent decrease. Individuals with immunocompromising conditions were less likely to have a positive PRNT (77%) compared with those who were not immunocompromised (92%; P = 0.04). Conclusion: Although the percentage of vaccinees with a positive PRNT and antibody titers decreased over time, a single dose of YF vaccine provided long-lasting protection in the majority of US travellers. A booster dose could be considered for certain travellers who are planning travel to a high risk area based on immune competence and time since vaccination.
Background: Few studies have assessed the duration of humoral immunity following yellow fever (YF) vaccination in a non-endemic population. We evaluated seropositivity among US resident travellers based on time post-vaccination. Methods: We identified serum samples from US travellers with YF virus-specific plaque reduction neutralization testing (PRNT) performed at CDC from 1988 to 2016. Analyses were conducted to assess the effect of time since vaccination on neutralizing antibody titer counts. Results: Among 234 travellers who had neutralizing antibody testing performed on a specimen obtained ≥1 month after vaccination, 13 received multiple YF vaccinations and 221 had one dose of YF vaccine reported. All 13 who received more than one dose of YF vaccine had a positive PRNT regardless of the amount time since most recent vaccination. Among the 221 travellers with one reported dose of YF vaccine, 155 (70%) were vaccinated within 10 years (range 1 month-9 years) and 66 (30%) were vaccinated ≥10 years (range 10-53 years) prior to serum collection. Among the 155 individuals vaccinated, <10 years prior to serum collection, 146 (94%) had a positive PRNT compared with 82% (54/66) of individuals vaccinated ≥10 years prior to serum collection (P = 0.01). Post-vaccination PRNT titers showed a time-dependent decrease. Individuals with immunocompromising conditions were less likely to have a positive PRNT (77%) compared with those who were not immunocompromised (92%; P = 0.04). Conclusion: Although the percentage of vaccinees with a positive PRNT and antibody titers decreased over time, a single dose of YF vaccine provided long-lasting protection in the majority of US travellers. A booster dose could be considered for certain travellers who are planning travel to a high risk area based on immune competence and time since vaccination.
Authors: Lorry G Rubin; Myron J Levin; Per Ljungman; E Graham Davies; Robin Avery; Marcie Tomblyn; Athos Bousvaros; Shireesha Dhanireddy; Lillian Sung; Harry Keyserling; Insoo Kang Journal: Clin Infect Dis Date: 2013-12-04 Impact factor: 9.079
Authors: Ana Maria Bispo de Filippis; Rita Maria Ribeiro Nogueira; Alfredo Verlangieri Jabor; Hermann G Schatzmayr; Janice Coelho Oliveira; Sonia C Machado Dinis; Ricardo Galler Journal: Vaccine Date: 2004-03-12 Impact factor: 3.641
Authors: Andréa Barbosa de Melo; Maria da Paz C da Silva; Maria Cecília F Magalhães; Laura Helena Vega Gonzales Gil; Eduardo M Freese de Carvalho; Ulisses M Braga-Neto; Giovani Rota Bertani; Ernesto T A Marques; Marli Tenório Cordeiro Journal: Am J Trop Med Hyg Date: 2011-10 Impact factor: 2.345
Authors: Céline M Gossner; Joana M Haussig; Chiara de Bellegarde de Saint Lary; Kaja Kaasik Aaslav; Patricia Schlagenhauf; Bertrand Sudre Journal: Euro Surveill Date: 2018-03
Authors: Ana Carolina Campi-Azevedo; Christiane Costa-Pereira; Lis R Antonelli; Cristina T Fonseca; Andréa Teixeira-Carvalho; Gabriela Villela-Rezende; Raiany A Santos; Maurício A Batista; Fernanda M Campos; Luiza Pacheco-Porto; Otoni A Melo Júnior; Débora M S H Hossell; Jordana G Coelho-dos-Reis; Vanessa Peruhype-Magalhães; Matheus F Costa-Silva; Jaquelline G de Oliveira; Roberto H Farias; Tatiana G Noronha; Jandira A Lemos; Vanessa dos R von Doellinger; Marisol Simões; Mirian M de Souza; Luiz C Malaquias; Harold R Persi; Jorge M Pereira; José A Martins; Marcos Dornelas-Ribeiro; Aline de A Vinhas; Tatiane R Alves; Maria de L Maia; Marcos da S Freire; Reinaldo de M Martins; Akira Homma; Alessandro P M Romano; Carla M Domingues; Pedro L Tauil; Pedro F Vasconcelos; Maria Rios; Iramaya R Caldas; Luiz A Camacho; Olindo Assis Martins-Filho Journal: Hum Vaccin Immunother Date: 2016 Impact factor: 3.452
Authors: Bettie W Kareko; Brian L Booty; Chad D Nix; Zoe L Lyski; Mark K Slifka; Ian J Amanna; William B Messer Journal: J Infect Dis Date: 2020-06-11 Impact factor: 7.759
Authors: Johanna E Huber; Julia Ahlfeld; Magdalena K Scheck; Magdalena Zaucha; Klaus Witter; Lisa Lehmann; Hadi Karimzadeh; Michael Pritsch; Michael Hoelscher; Frank von Sonnenburg; Andrea Dick; Giovanna Barba-Spaeth; Anne B Krug; Simon Rothenfußer; Dirk Baumjohann Journal: Clin Transl Immunology Date: 2020-05-13
Authors: Ricardo Arraes de Alencar Ximenes; Demócrito de Barros Miranda-Filho; Elizabeth B Brickley; Ulisses Ramos Montarroyos; Celina Maria Turchi Martelli; Thalia Velho Barreto de Araújo; Laura C Rodrigues; Maria de Fatima Pessoa Militão de Albuquerque; Wayner Vieira de Souza; Priscila Mayrelle da Silva Castanha; Rafael F O França; Rafael Dhália; Ernesto T A Marques Journal: PLoS Negl Trop Dis Date: 2019-10-07
Authors: Anna Z Wec; Denise Haslwanter; Yasmina N Abdiche; Laila Shehata; Nuria Pedreño-Lopez; Crystal L Moyer; Zachary A Bornholdt; Asparouh Lilov; Juergen H Nett; Rohit K Jangra; Michael Brown; David I Watkins; Clas Ahlm; Mattias N Forsell; Félix A Rey; Giovanna Barba-Spaeth; Kartik Chandran; Laura M Walker Journal: Proc Natl Acad Sci U S A Date: 2020-03-09 Impact factor: 11.205